The increase in activating EGFR mutation in plasma is an early biomarker to monitor response to osimertinib: a case report

Overview of attention for article published in BMC Cancer, April 2019

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (53rd percentile)
Good Attention Score compared to outputs of the same age and source (67th percentile)

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 42,984 followers.

@isliquidbiopsy

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.